U.S. scientists say they don't believe the theory that experimentation with marijuana is harmless and won't lead to further drug use.
Researchers at the Mount Sinai School of Medicine in New York note that, or cannabis, is often called a "gateway drug," suggesting addiction to one drug could make a person vulnerable to abuse and addiction of harder drugs.
The most common argument against the gateway drug theory is that adolescents move to harder drugs because of peer or emotional pressures. But now Professor Yasmin Hurd and colleagues say they've demonstrate in animal models that cannabis can affect future sensitivity to heroin.
Studying neurobiological events after cannabis exposure, they found marijuana affects the human brain's natural chemicals called endogenous opioids, which are known to play a role in heightening positive emotions, and creating a sense of reward. That's the same system stimulated by hard drugs.
The team's results dispel the common belief that drug experimentation doesn't affect the brain and demonstrates the brain may "remember" previous usage and make users vulnerable to harder drugs later in life.
The research appears in the online edition of the journal Neuropsychopharmacology.
Copyright 2006 by United Press International
Related stories:
Schizophrenia linked to dysfunction in molecular brain pathway activated by marijuana
Alterations in a molecular brain pathway activated by marijuana may contribute to the cognitive symptoms of schizophrenia, according to a report in the July issue of
Archives of General Psychiatry, one of the JAMA/Archives journals.
Researchers look at cannabinoids, genes, medicines and brain scans to find better anxiety treatments
Right now, about half of all people who take medicine for an anxiety disorder don’t get much help from it. And doctors have no definitive way to predict who will, and who won’t, benefit from each anti-anxiety prescription they write.
Cannabis indicated as possible risk for gum disease in young people
Young people who are heavy smokers of cannabis may be putting themselves at significant risk for periodontal disease, according to new research.
Regular marijuana use increases risk of hepatitis C-related liver damage
Patients with chronic hepatitis C (HCV) infection should not use marijuana (cannabis) daily, according to a study published in
Clinical Gastroenterology and Hepatology, the official journal of the American Gastroenterological Association (AGA) Institute. Researchers found that HCV patients who used cannabis daily were at significantly higher risk of moderate to severe liver fibrosis, or tissue scarring.
Marijuana withdrawal as bad as withdrawal from cigarettes
Research by a group of scientists studying the effects of heavy marijuana use suggests that withdrawal from the use of marijuana is similar to what is experienced by people when they quit smoking cigarettes. Abstinence from each of these drugs appears to cause several common symptoms, such as irritability, anger and trouble sleeping - based on self reporting in a recent study of 12 heavy users of both marijuana and cigarettes.
Experimental weight-loss drug cuts appetite, burns more energy
The first clinical studies of an experimental drug have revealed that obese people who take it for 12 weeks lose weight, even at very low doses. Short-term studies also suggest that the drug, called taranabant—the second drug designed to fight obesity by blocking cannabinoid receptors in the brain—causes people to consume fewer calories and burn more, researchers report in the January issue of
Cell Metabolism, a publication of Cell Press.
Opium and marijuana research go underground
The world’s leading expert on the opium poppy has joined forces with researchers working on another infamous drug-producing plant – cannabis – in hopes of finding new uses for the much-maligned sources of heroin and marijuana.
Cannabis/schizophrenia link questioned
The Swiss government is questioning the results of a study showing a link between marijuana use and schizophrenia.